KLOW 80mg is a four-component peptide blend combining GHK-Cu, BPC-157, TB-500, and KPV, supplied for research into converging tissue-repair and inflammatory signaling pathways. Supplied as a ≥98% HPLC-verified lyophilized powder for laboratory research use only.
€ 139.99
82 in stock
Third-Party Tested by Janoshik Analytical
Compound Information
Technical specifications
Co-lyophilized blend; keep sealed, dry, and protected from light
Distinct blue tint from copper coordination in the GHK-Cu component
Aliquot after reconstitution; avoid repeated freeze–thaw cycles
Lyophilized Powder
-20°C preferred; 2–8°C for short-term handling
Reconstituted
2–8°C
KLOW 80mg is a co-lyophilized blend of four synthetic peptides, each associated with a distinct arm of tissue-repair and inflammatory signaling. GHK-Cu is a copper-binding tripeptide studied for extracellular matrix remodeling; BPC-157 is a gastric-derived pentadecapeptide investigated for angiogenesis and cytoprotection; TB-500 is the active fragment of thymosin beta-4, researched for actin sequestration and cell migration; and KPV is the C-terminal fragment of α-MSH, examined for anti-inflammatory signaling through NF-κB. Supplying all four in a fixed ratio gives researchers a single reagent for studying how these pathways converge in multi-factorial repair models. The vial’s characteristic blue tint comes from copper coordination in the GHK-Cu component. Supplied as a high-purity lyophilized powder for laboratory research and development purposes only. Must be handled by qualified professionals. Not for human, therapeutic, or diagnostic use.
GHK-Cu — Matrix Remodeling
A copper-binding tripeptide studied for its role in extracellular matrix turnover and collagen synthesis signaling.
BPC-157 — Angiogenesis
A pentadecapeptide investigated for its influence on vascular formation and cytoprotective signaling in tissue models.
TB-500 — Cell Migration
The active fragment of thymosin beta-4, researched for actin sequestration and its effect on cell motility.
KPV — Inflammatory Signaling
The C-terminal fragment of α-MSH, examined for NF-κB modulation and epithelial barrier function.
Multi-Factorial Study Design
A fixed-ratio blend gives researchers one reagent for probing how four distinct repair pathways converge.
≥98% HPLC Purity
Every component is HPLC-verified and co-lyophilized, ensuring a consistent ratio across every vial.
